Who owns the REMIX THERAPEUTICS trademark?

The REMIX THERAPEUTICS trademark is owned by Remix Therapeutics Inc..

What is the serial number for REMIX THERAPEUTICS?

The USPTO serial number for REMIX THERAPEUTICS is 98195999.

What is the registration number for REMIX THERAPEUTICS?

REMIX THERAPEUTICS is registered under USPTO registration number 0.

REM

USPTO Trademark Record

PENDING

REMIX THERAPEUTICS

Q: What class is the REMIX THERAPEUTICS trademark registered in?

The REMIX THERAPEUTICS trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 98195999·Reg 0·Filed Sep 25, 2023

Owner Remix Therapeutics Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

REMIX THERAPEUTICS (Serial No. 98195999), Registration No. 0, is a pending US trademark filed on Sep 25, 2023 by Remix Therapeutics Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

Mark Intelligence

REMIX THERAPEUTICS (Reg. #0) is a pending US trademark that was filed in 2023 and is currently under USPTO examination. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Sep 25, 2023

SERIAL

98195999

REG#

Owner

Applicant

Remix Therapeutics Inc.

Entity

Corporation

State

Address

100 Forge Road, Suite 400, Watertown, MA, 02472

Country

Attorney

NameChristina Licursi

Law firm

Christina Licursi WOLF, GREENFIELD & SACKS, P.C.

Docket

R08262000400

Address

600 ATLANTIC AVENUE, BOSTON, MA 02210, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusPENDING

Filing DateSep 25, 2023

Serial Number98195999

Registration No.0

Status DateOct 14, 2026

Published for OppositionNov 26, 2024

Mark TypeDesign with words

Attorney DocketR08262000400

Status DescriptionLive and pending, statement of use sent to examiner

Filing Signals

FILED

2023

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Jun 30, 2026

First use in commerce: Jun 30, 2026

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Jun 30, 2026

First use in commerce: Jun 30, 2026

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

45 events

STATEMENT OF USE PROCESSING COMPLETE

Oct 14, 2026

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

Oct 06, 2026

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Oct 06, 2026

USE AMENDMENT FILED

SOU TEAS EXTENSION RECEIVED

Jul 02, 2026

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 3 FILED

Jul 02, 2026

SOU EXTENSION 3 FILED

SOU EXTENSION 3 GRANTED

Jul 02, 2026

SOU EXTENSION 3 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jul 02, 2026

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Jan 07, 2026

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Jan 07, 2026

SOU EXTENSION 2 FILED

SOU EXTENSION 2 GRANTED

Jan 07, 2026

SOU EXTENSION 2 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jan 07, 2026

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jul 08, 2025

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Jul 07, 2025

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Jul 07, 2025

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Jul 07, 2025

SOU EXTENSION 1 GRANTED

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Apr 23, 2025

TEAS CHANGE OF OWNER ADDRESS RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Apr 23, 2025

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Apr 23, 2025

TEAS CHANGE OF CORRESPONDENCE RECEIVED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jan 07, 2025

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Nov 26, 2024

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Nov 26, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Nov 20, 2024

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Oct 21, 2024

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Oct 21, 2024

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Oct 21, 2024

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Oct 21, 2024

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Oct 21, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

FINAL REFUSAL WRITTEN

Oct 03, 2024

FINAL REFUSAL WRITTEN

FINAL REFUSAL E-MAILED

Oct 03, 2024

FINAL REFUSAL E-MAILED

NOTIFICATION OF FINAL REFUSAL EMAILED

Oct 03, 2024

NOTIFICATION OF FINAL REFUSAL EMAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Sep 23, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Sep 23, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Sep 23, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Jun 27, 2024

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Jun 27, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jun 27, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jun 26, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jun 26, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jun 26, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

May 17, 2024

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

May 17, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

May 17, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

May 16, 2024

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE E-MAILED

Oct 11, 2023

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 10, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

REMIX THERAPEUTICS

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Remix Therapeutics Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Christina Licursi

Resources

Company